Physician

Ahmed Ali Dakka, MD

According to 2025 Medicare claims, Ahmed Dakka, MD (NPI: 1083110761) practices nephrology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Will, IL. This provider's primary affiliated billing organization is DUPAGE MEDICAL GROUP LTD (NPI: 1801833983; TIN: 36-2657618) and primary practice location at 60435-6565. Dakka is affiliated with the DULY HEALTH AND CARE ACCOUNTABLE CARE ORGANIZATION (ACO ID: D0265), participating under the REACH model.

Dakka's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 231 traditional Medicare patients, billed 1,914 HCPCS/CPT codes, and received $83,547 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 578 prescription claims across 113 beneficiaries totaling $104,683 in drug costs, led by Jardiance (Empagliflozin). Open Payments data shows 11 records totaling $156. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,016 to $104,683. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$42K$84K2023 Medicare payment: $7,831 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $83,547 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202331247$7,831
20242311,914$83,547

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$52K$105K2018 Drug cost: $3,016 (USD; Tot_Drug_Cst)2019 Drug cost: $9,547 (USD; Tot_Drug_Cst)2020 Drug cost: $26,372 (USD; Tot_Drug_Cst)2021 Drug cost: $9,827 (USD; Tot_Drug_Cst)2022 Drug cost: $4,118 (USD; Tot_Drug_Cst)2023 Drug cost: $37,507 (USD; Tot_Drug_Cst)2024 Drug cost: $104,683 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182559$3,016
201975209$9,547
202087316$26,372
202159168$9,827
20223070$4,118
202350150$37,507
2024113578$104,683

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes7781$139
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes124408$95
36415Insertion of needle into vein for collection of blood sample87207$8
80069Kidney function blood test panel79162$8
82570Creatinine level to test for kidney function or muscle injury80179$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin652,670$50,578
KerendiaFinerenone231,170$24,900
Nifedipine ErNifedipine594,395$1,602
Potassium ChloridePotassium Chloride512,103$1,226
Sodium Polystyrene SulfonateSodium Polystyrene Sulfonate11343$1,070

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$156AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ahmed Ali Dakka, MD?

Tedicare shows public-source Medicare data for Ahmed Ali Dakka, MD (NPI 1083110761), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed Ali Dakka, MD have ACO affiliation data?

Ahmed Ali Dakka, MD is shown with ACO affiliation data for DULY HEALTH AND CARE ACCOUNTABLE CARE ORGANIZATION (REACH, ACO ID D0265).

What billing organization is linked to Ahmed Ali Dakka, MD?

Ahmed Ali Dakka, MD is linked to DUPAGE MEDICAL GROUP LTD (billing NPI 1801833983) in the available physician profile data.

Does Ahmed Ali Dakka, MD have Open Payments data?

Ahmed Ali Dakka, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.